Potential role of subcutaneous tocilizumab injections in patients with COVID‐19 associated pneumonia

Giuseppe Greco,Diego Ripamonti,Francesca Binda,Fabrizio Fabretti,Lorenzo Grazioli,Marco Rizzi

JOURNAL OF MEDICAL VIROLOGY（2020）

引用 1|浏览0

暂无评分

摘要

Guaraldi et al. found a significant reduction in risk of invasive mechanical ventilation or death in patients with severe COVID-19 pneumonia who were treated with either I.V. or S.C. tocilizumab and standard of care, compared with those treated with standard of care only. This article is protected by copyright. All rights reserved.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要